TY  - JOUR
AU  - Pereyaslov, D.
AU  - Rosin, P.
AU  - Palm, D.
AU  - Zeller, H.
AU  - Gross, D.
AU  - Brown, C.S.
AU  - Struelens, M.J.
AU  - Robo, Alma
AU  - Hatibi, I.H.
AU  - Alis, J.C.
AU  - Sargsyan, S.
AU  - Gurbanov, S.
AU  - Gribkova, N.
AU  - van Ranst, M.
AU  - Ieven, G.
AU  - Patteet, S.
AU  - Tomić, S.
AU  - Korsun, N.
AU  - Drazenović, V.
AU  - Pieridou-Bagkatzouni, D.
AU  - Jirincova, H.
AU  - Havlickova, M.
AU  - Fomsgaard, A.
AU  - Rae, K.
AU  - Lappalainen, M.
AU  - Ikonen, N.
AU  - Lina, B.
AU  - van der Werf, S.
AU  - Manuguerra, J.-C.
AU  - Machablishvili, A.
AU  - Eickmann, M.
AU  - Wolff, T.
AU  - Dobler, G.
AU  - Schmidt-Chanasit, J.
AU  - Drosten, C.
AU  - Papa, Anna
AU  - Mentis, Andreas F.
AU  - Kis, Z.
AU  - Löve, A.
AU  - Coughlan, S.
AU  - Mandelboim, M.
AU  - Capobianchi, M.R.
AU  - Landini, M.P.
AU  - Baldanti, F.
AU  - Palu, G.
AU  - Ghisetti, V.
AU  - Donatelli, I.
AU  - Nusupbayeva, G.
AU  - Tokhtabakiyeva, Z.
AU  - Kasymbekova, Kalia
AU  - Storozenko, J.
AU  - Erne, S.
AU  - Griskevicius, A.
AU  - Opp, M.
AU  - Barbara, C.
AU  - Vratnica, Z.
AU  - Reusken, C.
AU  - Dudman, S.G.
AU  - Hungnes, O.
AU  - Pancer, K.
AU  - Guiomar, R.
AU  - Eder, V.
AU  - Lupulescu, Emilia
AU  - Yatsyshina, S.
AU  - Pisareva, M.
AU  - Buzitskaya, Z.
AU  - Sergeev, A.
AU  - Nedeljković, Jasminka
AU  - Staroňová, E.
AU  - Županc, T.A.
AU  - Petrovec, M.
AU  - Korva, M.
AU  - Prosenc, K.
AU  - Casas, I.
AU  - Gaines, H.
AU  - Cherpillod, P.
AU  - Zakirova, N.
AU  - Bosevska, G.
AU  - Altas, B.
AU  - Ciblak, M.
AU  - Ciblak, M.
AU  - Mironenko, A.
AU  - Dykhanovska, T.
AU  - Demchyshyna, Irina V.
AU  - Bermingham, A.
AU  - Rakhimov, R.
PY  - 2014
UR  - http://intor.torlakinstitut.com/handle/123456789/416
AB  - Since September 2012, over 90 cases of respiratory disease caused by a novel coronavirus, now named Middle East respiratory syndrome coronavirus (MERS-CoV), have been reported in the Middle East and Europe. To ascertain the capabilities and testing experience of national reference laboratories across the World Health Organization (WHO) European Region to detect this virus, the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe conducted a joint survey in November 2012 and a follow-up survey in June 2013. In 2013, 29 of 52 responding WHO European Region countries and 24 of 31 countries of the European Union/European Economic Area (EU/EEA) had laboratory capabilities to detect and confirm MERS-CoV cases, compared with 22 of 46 and 18 of 30 countries, respectively, in 2012. By June 2013, more than 2,300 patients had been tested in 23 countries in the WHO European Region with nine laboratory-confirmed MERS-CoV cases. These data indicate that the Region has developed significant capability to detect this emerging virus in accordance with WHO and ECDC guidance. However, not all countries had developed capabilities, and the needs to do so should be addressed. This includes enhancing collaborations between countries to ensure diagnostic capabilities for surveillance of MERS-CoV infections across the European Region.
PB  - European Centre for Disease Prevention and Control (ECDC)
T2  - Eurosurveillance
T1  - Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013
IS  - 40
VL  - 19
DO  - 10.2807/1560-7917.ES2014.19.40.20923
ER  - 

@article{
author = "Pereyaslov, D. and Rosin, P. and Palm, D. and Zeller, H. and Gross, D. and Brown, C.S. and Struelens, M.J. and Robo, Alma and Hatibi, I.H. and Alis, J.C. and Sargsyan, S. and Gurbanov, S. and Gribkova, N. and van Ranst, M. and Ieven, G. and Patteet, S. and Tomić, S. and Korsun, N. and Drazenović, V. and Pieridou-Bagkatzouni, D. and Jirincova, H. and Havlickova, M. and Fomsgaard, A. and Rae, K. and Lappalainen, M. and Ikonen, N. and Lina, B. and van der Werf, S. and Manuguerra, J.-C. and Machablishvili, A. and Eickmann, M. and Wolff, T. and Dobler, G. and Schmidt-Chanasit, J. and Drosten, C. and Papa, Anna and Mentis, Andreas F. and Kis, Z. and Löve, A. and Coughlan, S. and Mandelboim, M. and Capobianchi, M.R. and Landini, M.P. and Baldanti, F. and Palu, G. and Ghisetti, V. and Donatelli, I. and Nusupbayeva, G. and Tokhtabakiyeva, Z. and Kasymbekova, Kalia and Storozenko, J. and Erne, S. and Griskevicius, A. and Opp, M. and Barbara, C. and Vratnica, Z. and Reusken, C. and Dudman, S.G. and Hungnes, O. and Pancer, K. and Guiomar, R. and Eder, V. and Lupulescu, Emilia and Yatsyshina, S. and Pisareva, M. and Buzitskaya, Z. and Sergeev, A. and Nedeljković, Jasminka and Staroňová, E. and Županc, T.A. and Petrovec, M. and Korva, M. and Prosenc, K. and Casas, I. and Gaines, H. and Cherpillod, P. and Zakirova, N. and Bosevska, G. and Altas, B. and Ciblak, M. and Ciblak, M. and Mironenko, A. and Dykhanovska, T. and Demchyshyna, Irina V. and Bermingham, A. and Rakhimov, R.",
year = "2014",
abstract = "Since September 2012, over 90 cases of respiratory disease caused by a novel coronavirus, now named Middle East respiratory syndrome coronavirus (MERS-CoV), have been reported in the Middle East and Europe. To ascertain the capabilities and testing experience of national reference laboratories across the World Health Organization (WHO) European Region to detect this virus, the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe conducted a joint survey in November 2012 and a follow-up survey in June 2013. In 2013, 29 of 52 responding WHO European Region countries and 24 of 31 countries of the European Union/European Economic Area (EU/EEA) had laboratory capabilities to detect and confirm MERS-CoV cases, compared with 22 of 46 and 18 of 30 countries, respectively, in 2012. By June 2013, more than 2,300 patients had been tested in 23 countries in the WHO European Region with nine laboratory-confirmed MERS-CoV cases. These data indicate that the Region has developed significant capability to detect this emerging virus in accordance with WHO and ECDC guidance. However, not all countries had developed capabilities, and the needs to do so should be addressed. This includes enhancing collaborations between countries to ensure diagnostic capabilities for surveillance of MERS-CoV infections across the European Region.",
publisher = "European Centre for Disease Prevention and Control (ECDC)",
journal = "Eurosurveillance",
title = "Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013",
number = "40",
volume = "19",
doi = "10.2807/1560-7917.ES2014.19.40.20923"
}

Pereyaslov, D., Rosin, P., Palm, D., Zeller, H., Gross, D., Brown, C.S., Struelens, M.J., Robo, A., Hatibi, I.H., Alis, J.C., Sargsyan, S., Gurbanov, S., Gribkova, N., van Ranst, M., Ieven, G., Patteet, S., Tomić, S., Korsun, N., Drazenović, V., Pieridou-Bagkatzouni, D., Jirincova, H., Havlickova, M., Fomsgaard, A., Rae, K., Lappalainen, M., Ikonen, N., Lina, B., van der Werf, S., Manuguerra, J.-C., Machablishvili, A., Eickmann, M., Wolff, T., Dobler, G., Schmidt-Chanasit, J., Drosten, C., Papa, A., Mentis, A. F., Kis, Z., Löve, A., Coughlan, S., Mandelboim, M., Capobianchi, M.R., Landini, M.P., Baldanti, F., Palu, G., Ghisetti, V., Donatelli, I., Nusupbayeva, G., Tokhtabakiyeva, Z., Kasymbekova, K., Storozenko, J., Erne, S., Griskevicius, A., Opp, M., Barbara, C., Vratnica, Z., Reusken, C., Dudman, S.G., Hungnes, O., Pancer, K., Guiomar, R., Eder, V., Lupulescu, E., Yatsyshina, S., Pisareva, M., Buzitskaya, Z., Sergeev, A., Nedeljković, J., Staroňová, E., Županc, T.A., Petrovec, M., Korva, M., Prosenc, K., Casas, I., Gaines, H., Cherpillod, P., Zakirova, N., Bosevska, G., Altas, B., Ciblak, M., Ciblak, M., Mironenko, A., Dykhanovska, T., Demchyshyna, I. V., Bermingham, A.,& Rakhimov, R.. (2014). Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013. in Eurosurveillance
European Centre for Disease Prevention and Control (ECDC)., 19(40).
https://doi.org/10.2807/1560-7917.ES2014.19.40.20923

Pereyaslov D, Rosin P, Palm D, Zeller H, Gross D, Brown C, Struelens M, Robo A, Hatibi I, Alis J, Sargsyan S, Gurbanov S, Gribkova N, van Ranst M, Ieven G, Patteet S, Tomić S, Korsun N, Drazenović V, Pieridou-Bagkatzouni D, Jirincova H, Havlickova M, Fomsgaard A, Rae K, Lappalainen M, Ikonen N, Lina B, van der Werf S, Manuguerra J, Machablishvili A, Eickmann M, Wolff T, Dobler G, Schmidt-Chanasit J, Drosten C, Papa A, Mentis AF, Kis Z, Löve A, Coughlan S, Mandelboim M, Capobianchi M, Landini M, Baldanti F, Palu G, Ghisetti V, Donatelli I, Nusupbayeva G, Tokhtabakiyeva Z, Kasymbekova K, Storozenko J, Erne S, Griskevicius A, Opp M, Barbara C, Vratnica Z, Reusken C, Dudman S, Hungnes O, Pancer K, Guiomar R, Eder V, Lupulescu E, Yatsyshina S, Pisareva M, Buzitskaya Z, Sergeev A, Nedeljković J, Staroňová E, Županc T, Petrovec M, Korva M, Prosenc K, Casas I, Gaines H, Cherpillod P, Zakirova N, Bosevska G, Altas B, Ciblak M, Ciblak M, Mironenko A, Dykhanovska T, Demchyshyna IV, Bermingham A, Rakhimov R. Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013. in Eurosurveillance. 2014;19(40).
doi:10.2807/1560-7917.ES2014.19.40.20923 .

Pereyaslov, D., Rosin, P., Palm, D., Zeller, H., Gross, D., Brown, C.S., Struelens, M.J., Robo, Alma, Hatibi, I.H., Alis, J.C., Sargsyan, S., Gurbanov, S., Gribkova, N., van Ranst, M., Ieven, G., Patteet, S., Tomić, S., Korsun, N., Drazenović, V., Pieridou-Bagkatzouni, D., Jirincova, H., Havlickova, M., Fomsgaard, A., Rae, K., Lappalainen, M., Ikonen, N., Lina, B., van der Werf, S., Manuguerra, J.-C., Machablishvili, A., Eickmann, M., Wolff, T., Dobler, G., Schmidt-Chanasit, J., Drosten, C., Papa, Anna, Mentis, Andreas F., Kis, Z., Löve, A., Coughlan, S., Mandelboim, M., Capobianchi, M.R., Landini, M.P., Baldanti, F., Palu, G., Ghisetti, V., Donatelli, I., Nusupbayeva, G., Tokhtabakiyeva, Z., Kasymbekova, Kalia, Storozenko, J., Erne, S., Griskevicius, A., Opp, M., Barbara, C., Vratnica, Z., Reusken, C., Dudman, S.G., Hungnes, O., Pancer, K., Guiomar, R., Eder, V., Lupulescu, Emilia, Yatsyshina, S., Pisareva, M., Buzitskaya, Z., Sergeev, A., Nedeljković, Jasminka, Staroňová, E., Županc, T.A., Petrovec, M., Korva, M., Prosenc, K., Casas, I., Gaines, H., Cherpillod, P., Zakirova, N., Bosevska, G., Altas, B., Ciblak, M., Ciblak, M., Mironenko, A., Dykhanovska, T., Demchyshyna, Irina V., Bermingham, A., Rakhimov, R., "Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013" in Eurosurveillance, 19, no. 40 (2014),
https://doi.org/10.2807/1560-7917.ES2014.19.40.20923 . .

TY  - JOUR
AU  - Huebschen, Judith M.
AU  - Mihneva, Zefira
AU  - Mentis, Andreas F.
AU  - Schneider, Francois
AU  - Aboudy, Yair
AU  - Grossman, Zehava
AU  - Rudich, Hagit
AU  - Kasymbekova, Kalia
AU  - Sarv, Inna
AU  - Nedeljković, Jasminka
AU  - Tahita, Marc C.
AU  - Tarnagda, Zekiba
AU  - Ouedraogo, Jean-Bosco
AU  - Gerasimova, A.G.
AU  - Moskaleva, T.N.
AU  - Tikhonova, Nina T.
AU  - Chitadze, Nazibrola
AU  - Forbi, J.C.
AU  - Faneye, Adedayo O.
AU  - Otegbayo, Jesse A.
AU  - Charpentier, Emilie
AU  - Muller, Claude P.
PY  - 2009
UR  - http://intor.torlakinstitut.com/handle/123456789/279
AB  - Phylogenetic analysis of 166 human parvovirus B19 sequences from 11 different countries attributed 91.57% to genotype 1, 5.42% to genotype 3b, and 3.01% to genotype 3a. Very similar viruses of genotype 1 circulated widely in Europe and Israel. Genotype 3b seems to show an increasing spread outside of Africa.
PB  - Amer Soc Microbiology, Washington
T2  - Journal of Clinical Microbiology
T1  - Phylogenetic Analysis of Human Parvovirus B19 Sequences from Eleven Different Countries Confirms the Predominance of Genotype 1 and Suggests the Spread of Genotype 3b
EP  - 3738
IS  - 11
SP  - 3735
VL  - 47
DO  - 10.1128/JCM.01201-09
ER  - 

@article{
author = "Huebschen, Judith M. and Mihneva, Zefira and Mentis, Andreas F. and Schneider, Francois and Aboudy, Yair and Grossman, Zehava and Rudich, Hagit and Kasymbekova, Kalia and Sarv, Inna and Nedeljković, Jasminka and Tahita, Marc C. and Tarnagda, Zekiba and Ouedraogo, Jean-Bosco and Gerasimova, A.G. and Moskaleva, T.N. and Tikhonova, Nina T. and Chitadze, Nazibrola and Forbi, J.C. and Faneye, Adedayo O. and Otegbayo, Jesse A. and Charpentier, Emilie and Muller, Claude P.",
year = "2009",
abstract = "Phylogenetic analysis of 166 human parvovirus B19 sequences from 11 different countries attributed 91.57% to genotype 1, 5.42% to genotype 3b, and 3.01% to genotype 3a. Very similar viruses of genotype 1 circulated widely in Europe and Israel. Genotype 3b seems to show an increasing spread outside of Africa.",
publisher = "Amer Soc Microbiology, Washington",
journal = "Journal of Clinical Microbiology",
title = "Phylogenetic Analysis of Human Parvovirus B19 Sequences from Eleven Different Countries Confirms the Predominance of Genotype 1 and Suggests the Spread of Genotype 3b",
pages = "3738-3735",
number = "11",
volume = "47",
doi = "10.1128/JCM.01201-09"
}

Huebschen, J. M., Mihneva, Z., Mentis, A. F., Schneider, F., Aboudy, Y., Grossman, Z., Rudich, H., Kasymbekova, K., Sarv, I., Nedeljković, J., Tahita, M. C., Tarnagda, Z., Ouedraogo, J., Gerasimova, A.G., Moskaleva, T.N., Tikhonova, N. T., Chitadze, N., Forbi, J.C., Faneye, A. O., Otegbayo, J. A., Charpentier, E.,& Muller, C. P.. (2009). Phylogenetic Analysis of Human Parvovirus B19 Sequences from Eleven Different Countries Confirms the Predominance of Genotype 1 and Suggests the Spread of Genotype 3b. in Journal of Clinical Microbiology
Amer Soc Microbiology, Washington., 47(11), 3735-3738.
https://doi.org/10.1128/JCM.01201-09

Huebschen JM, Mihneva Z, Mentis AF, Schneider F, Aboudy Y, Grossman Z, Rudich H, Kasymbekova K, Sarv I, Nedeljković J, Tahita MC, Tarnagda Z, Ouedraogo J, Gerasimova A, Moskaleva T, Tikhonova NT, Chitadze N, Forbi J, Faneye AO, Otegbayo JA, Charpentier E, Muller CP. Phylogenetic Analysis of Human Parvovirus B19 Sequences from Eleven Different Countries Confirms the Predominance of Genotype 1 and Suggests the Spread of Genotype 3b. in Journal of Clinical Microbiology. 2009;47(11):3735-3738.
doi:10.1128/JCM.01201-09 .

Huebschen, Judith M., Mihneva, Zefira, Mentis, Andreas F., Schneider, Francois, Aboudy, Yair, Grossman, Zehava, Rudich, Hagit, Kasymbekova, Kalia, Sarv, Inna, Nedeljković, Jasminka, Tahita, Marc C., Tarnagda, Zekiba, Ouedraogo, Jean-Bosco, Gerasimova, A.G., Moskaleva, T.N., Tikhonova, Nina T., Chitadze, Nazibrola, Forbi, J.C., Faneye, Adedayo O., Otegbayo, Jesse A., Charpentier, Emilie, Muller, Claude P., "Phylogenetic Analysis of Human Parvovirus B19 Sequences from Eleven Different Countries Confirms the Predominance of Genotype 1 and Suggests the Spread of Genotype 3b" in Journal of Clinical Microbiology, 47, no. 11 (2009):3735-3738,
https://doi.org/10.1128/JCM.01201-09 . .